Iqbal A, Suryawanshi R, Yadavalli T, Volety I, et al. Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814]. Antiviral Res 2022 Mar 22:105293. doi: 10.1016/j.antiviral.2022.105293.
PMID: 35337670